Proteomic Analysis of the Secretome and Exosomes of Feline Adipose-Derived Mesenchymal Stem Cells.

Animals (Basel)

Laboratory of Bioengineering and Tissue Regeneration, Department of Cell Biology, Genetics and Physiology, University of Málaga, IBIMA, 29071 Málaga, Spain.

Published: January 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Mesenchymal stem cells (MSCs) have been shown to have therapeutic efficacy in different complex pathologies in feline species. This effect is attributed to the secretion of a wide variety of bioactive molecules and extracellular vesicles, such as exosomes, with significant paracrine activity, encompassed under the concept of the secretome. However, at present, the exosomes from feline MSCs have not yet been studied in detail. The objective of this study is to analyze and compare the protein profiles of the secretome as a whole and its exosomal fraction from feline adipose-derived MSCs (fAd-MSCs). For this, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Protein-Protein Interaction Networks Functional Enrichment Analysis (STRING) were utilized. A total of 239 proteins were identified in the secretome, and 228 proteins specific to exosomes were identified, with a total of 133 common proteins. The proteins identified in the secretome were located in the extracellular regions and in the cytoplasm, while the exosomal proteins were located mainly in the membrane, cytoplasm and cytosol. Regarding function, in the secretome, proteins involved in different metabolic pathways, in pathways related to the immune system and the endocrine system and in the processing of proteins in the endoplasmic reticulum predominated. In contrast, proteins specific to exosomes were predominantly associated with endocytosis, cell junctions, platelet activation and other cell signaling pathways. The possible future use of the secretome, or some of its components, such as exosomes, would provide a non-cell-based therapeutic strategy for the treatment of different diseases that would avoid the drawbacks of cell therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912403PMC
http://dx.doi.org/10.3390/ani11020295DOI Listing

Publication Analysis

Top Keywords

secretome exosomes
8
exosomes feline
8
feline adipose-derived
8
mesenchymal stem
8
stem cells
8
proteins
8
proteins identified
8
identified secretome
8
proteins specific
8
specific exosomes
8

Similar Publications

Rotator cuff tears (RCTs) are a prevalent cause of shoulder dysfunction, with postoperative retearing remaining a significant challenge due to poor tendon-to-bone healing. Mesenchymal stem cells (MSCs), owing to their multipotency, immunomodulatory properties, and diverse tissue sources, have emerged as a promising therapeutic strategy. Current approaches include direct MSC implantation, MSC-laden scaffolds for structural support, and utilization of MSC-derived conditioned medium (CM) or exosomes to enhance regeneration.

View Article and Find Full Text PDF

Background: Every year, millions of infants are born prematurly, many of whom develop serious complications like bronchopulmonary dysplasia and necrotizing enterocolitis. Despite improvements in neonatal care, there are few therapies that actively promote healing or prevent long-term damage. In recent years, secretions from mesenchymal stem cells, rich in reparative proteins and tiny extracellular particles have shown promise as a safe and effective way to support tissue repair without the risks of live-cell therapy.

View Article and Find Full Text PDF

Extracellular vesicle (EV)-based therapies have attracted considerable attention as a novel class of biologics with broad clinical potential. However, their clinical translation is impeded by the fragmented and rapidly evolving regulatory landscape, with significant disparities between the United States, European Union, and key Asian jurisdictions. In this review, we systematically analyze regional guidelines and strategic frameworks governing EV therapeutics, emphasizing critical hurdles in quality control, safety evaluation, and efficacy demonstration.

View Article and Find Full Text PDF

The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Regulates the Na-Glucose Transporter SGLT1 in Intestinal Epithelial Cells.

Cells

August 2025

Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, 1 John Marshall Drive, Huntington, WV 25703, USA.

Obesity is a complex chronic inflammatory condition that results from excess fat accumulation. It increases the risk of developing numerous co-morbidities such as Type 2 diabetes mellitus, cardiovascular disease, hypertension, and stroke. The adipose tissue is itself a vital endocrine organ that secretes numerous adipokines, cytokines, and exosomes, which are collectively known as the adipose-derived secretome (ADS).

View Article and Find Full Text PDF

The Molecular Dynamics of Extracellular Vesicles and their Protein Corona in the Secretomes of Stem Cells.

Stem Cell Rev Rep

August 2025

Laboratory of Stem Cells and Tissue Regeneration, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, South Korea.

Stem cells play a crucial role in tissue repair, not only by differentiating into progeny that directly replace damaged tissues, but also by secreting diverse factors that support host regeneration. Among these regenerative signals, extracellular vesicles released by stem cells (SC-EVs) have emerged as key mediators of intercellular communication. SC-EVs contribute to tissue repair by delivering their molecular cargo to recipient cells, modulating signaling pathways, metabolic processes, and gene expression.

View Article and Find Full Text PDF